metaPreg - Eletriptan during pregnancy

Eletriptan

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	1.53 [0.16, 14.93]	88%	2 studies	56,784	203	not evaluable	ROB	-
Major congenital malformations	0.32 [0.10, 1.03]	-	1 study	15	189	not evaluable	ROB	-
Growth parameters and prematurity
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Low birth weight (< 2500g)	0.73 [0.26, 2.04]	-	1 study	15	207	not evaluable	ROB	-
Preterm (< 37 weeks)	0.56 [0.23, 1.35]	-	1 study	22	207	not evaluable	ROB	-
Small for gestational age (weight)	1.40 [0.68, 2.88]	-	1 study	34	207	not evaluable	ROB	-
Maternal consequences
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Postpartum hemorrhage	0.75 [0.44, 1.30]	-	1 study	62	207	not evaluable	ROB	-
Neonatal disorders
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Neonatal medical care	0.31 [0.04, 2.44]	-	1 study	25	21	not evaluable	ROB	-
Hide endpoints reported in only one study ...